ESR1 and breast carcinoma: RT-PCR detections confirmed that only 2 of the 19 (10.5%) ER positive breast cancer cell lines existed ACSL4 mRNA expression, and ACSL4 mRNA was broadly expressed in 20 of 31 (64.5%) ER negative cell lines (Monaco et al., 2010).